Search Results | Showing 11 - 20 of 20 results for "Bayer" |
| | | ... irrigation service and was also recently backed by Robert Bosch Venture Capital GmbH and the Flex technology accelerator Lab IX. Bayer and AVAC are among strategic investors in the fund. |
| | | | ... Kong and unveiling plans to expand to London later this year. CBA group executive institutional banking and markets, Kelly Bayer Rosmarin, said Hong Kong's developed financial sector, entrepreneurial culture and proximity to China made it an optimal ... |
| | | | ... institutional banking business accounted for less than 1% of overall net profit after tax at the most recent results. Kelly Bayer Rosmarin, group executive for institutional banking and markets said, "Making the decision to discontinue this team has ... |
| | | | ... independence vote. Frankfurt's DAX index jumped 1.41 per cent to 9,798.13 points, led by a surge in its second-largest company Bayer, while in Paris, the CAC 40 rose 0.75 per cent to close the day at 4,464.70 points. "Last night's absence of any real ... |
| | | | ... maker Merck meanwhile sank 1.8 per cent, continuing its fall since announcing a deal to sell its consumer-care business to Bayer for $US14.2 billion ($A15.4 billion). Tesla, the electric sports car maker whose first quarter earnings and outlook disappointed ... |
| | | | UBS Global Asset Management (GAM) has secured a global real estate multi-manager mandate from Germany's largest pension fund, Bayerische Versorgungskammer, valued at around EUR 500 million. Under the mandate, UBS Global Asset Management's Global Real ... |
| | | | ... results. The London FTSE 100 index gained 18.69, or 0.41 per cent, to close at 4547.53 points. FRANKFURT - Pharmaceutical group Bayer surged 5.44 per cent to 42.23 euros after reporting results that beat expectations. Despite a third consecutive quarterly ... |
| | | | While global property is becoming a 'must-have' strategy for local institutional investors, overseas investors with the same idea are coming to Australia to buy into the local market. The attractiveness of the Australian property market has lured, according ... |
| | | | ... growth stocks like blood plasma products supplier CSL, which jumped $1.00 or 6.08 per cent to $17.45 after German competitor Bayer AG said it planned to sell most of its blood products operations. "When the growth bias is in this market, the banks are ... |
|